 |
|
 |
 |
 |
MedDRA Literature Articles
|
MedDRA Literature Articles |
MSSO Response |
Dupuch M, Lerch M, Jamet A, Jaulent MC, Fescharek R, Grabar N. Grouping pharmacovigilance terms with semantic distance. Stud Health Technol Inform. 2011;169:794-8 |
|
Raschi E, Piccinni C, Poluzzi E, Marchesini G, De Ponti F. The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. 1) Acta Diabetol. 2011 Oct 19. [Epub ahead of print] |
|
Berlin C, Blanch C, Lewis DJ, Maladorno DD, Michel C, Petrin M, Sarp S, Close P. Are all quantitative postmarketing signal detection methods equal? Performance characteristics of logistic regression and Multi-item Gamma Poisson Shrinker. 2) Pharmacoepidemiol Drug Saf. 2011 Oct 12. doi: 10.1002/pds.2247. [Epub ahead of print] |
|
Budnitz, DS, Lovegrove, MC, Shehab, N, Richards, CL. Emergency Hospitalizations for Adverse Drug Events in Older Americans. N Engl J Med 2011; 365:2002-12 |
|
Moore, TJ, Furberg, CD, Glenmullen, J, Maltsberger, JT, Singh, S. Suicidal behavior and depression in smoking cessation treatments. PLoS One. 2011;6(11):e27016. Epub 2011 Nov 2 |
|
Nadkarni, PM and Darer, JD. Determining correspondences between high-frequency MedDRA concepts and SNOMED: a case study. BMC Medical Informatics and Decision Making 2010, 10:66 |
MSSO Response |
Ooba, N and Kubota, K. Selected control events and reporting odds ratio in signal detection methodology. Pharmacoepidemiology and Drug Safety 2010; DOI: 10.1002/pds |
|
Bakare N, Menschik D, Tiernan R, Hua W, Martin D. Severe combined immunodeficiency (SCID) and rotavirus vaccination: Reports to the Vaccine Adverse Events Reporting System (VAERS). Vaccine. 2010 Jul 30. [Epub ahead of print] |
|
Lapi F, Tuccori M, Motola D, Pugi A, Vietri M, Montanaro N, Vaccheri A, Leoni O, Cocci A, Leone R, Conforti A, Moretti U, Sessa E, Mazzaglia G, Mugelli A, Mazzei T, Vannacci A. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy. Drug Saf. 2010 Sep 1;33(9):789-99 |
|
Levi, M, Levy, JH, Andersen, HF and Truloff, D. Safety of recombinant activated Factor VII in randomized clinical trials. N Engl J Med 2010; 363(19): 1791 - 1800 |
|
Hammar N, Farahmand B, Gran M, Joelson S, Andersson SW. Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials. Pharmacoepidemiol Drug Saf. 2010 Oct 21. [Epub ahead of print] |
|
Wang, HW, Hochberg, AM, Pearson, RK and Hauben, M. An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database. Drug Saf 2010; 33 (12): 1117-1133 |
|
Gäwert L, Hierse F, Zink A, Strangfeld A. The importance of patient perspective in drug surveillance systems. Z Rheumatol. 2010 Nov;69(9):795-802 |
|
| Delamarre D, Lillo-Le Louët A, Guillot L, Jamet A, Sadou E, Ouazine T, Burgun A, Jaulent MC. Documentation in Pharmacovigilance: Using an ontology to extend and normalize Pubmed queries. Stud Health Technol Inform. 2010;160:518-22 | |
| Giezen, TJ, Mantel-Teeuwisse, AK, Meyboom, RHB, Strauss, SMJM, Leufkens, HGM and Egberts, TCG. Mapping the safety profile of biologicals: adisproportionality analysis using the WHO Adverse Drug Reaction Database, Vigibase. Drug Safety 2010; 33(10): 865 - 878 |
mssohelp@mssotools.com |
MedDRA MSSO |
 |
|